99 related articles for article (PubMed ID: 1478629)
1. Growth after radiotherapy and chemotherapy in children with leukemia or lymphoma.
Thun-Hohenstein L; Frisch H; Schuster E
Horm Res; 1992; 37(3):91-5. PubMed ID: 1478629
[TBL] [Abstract][Full Text] [Related]
2. [Effect of various therapeutic protocols on growth and final height of children with acute lymphoblastic leukemia or non-Hodgkin's lymphoma].
Timme J; Mittler U; Mohnike K; Dörffel W
Klin Padiatr; 1995; 207(5):267-70. PubMed ID: 7500601
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal growth in children with non-Hodgkin's lymphoma and children with acute lymphoblastic leukemia: comparison between unirradiated and irradiated patients.
Márky I; Samuelsson BO; Mellander L; Karlberg J
Med Pediatr Oncol; 1991; 19(2):96-9. PubMed ID: 2011102
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation.
Haddy TB; Mosher RB; Nunez SB; Reaman GH
Pediatr Blood Cancer; 2006 Feb; 46(2):258-61. PubMed ID: 16369923
[TBL] [Abstract][Full Text] [Related]
5. Pubertal growth in young adult survivors of childhood leukemia.
Didcock E; Davies HA; Didi M; Ogilvy Stuart AL; Wales JK; Shalet SM
J Clin Oncol; 1995 Oct; 13(10):2503-7. PubMed ID: 7595700
[TBL] [Abstract][Full Text] [Related]
6. A longitudinal study of growth and growth hormone secretion in children during treatment for acute lymphoblastic leukemia.
Màrky I; Mellander L; Lannering B; Albertsson-Wikland K
Med Pediatr Oncol; 1991; 19(4):258-64. PubMed ID: 2056970
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic cranial irradiation of acute lymphoblastic leukemia in childhood: outcomes of late effects on pituitary function and growth in long-term survivors.
Hata M; Ogino I; Aida N; Saito K; Omura M; Kigasawa H; Toyoda Y; Tachibana K; Matsubara S; Inoue T
Int J Cancer; 2001; 96 Suppl():117-24. PubMed ID: 11992395
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging of the pituitary area in children treated for acute lymphoblastic leukemia with low-dose (18-Gy) cranial irradiation. Relationships to growth and growth hormone secretion.
Cicognani A; Cacciari E; Carlá G; Rosito P; Cau M; Mancini AF; Zucchini S; Vecchi V; Pirazzoli P; Paolucci G
Am J Dis Child; 1992 Nov; 146(11):1343-8. PubMed ID: 1415076
[TBL] [Abstract][Full Text] [Related]
9. Growth and puberty after treatment for acute lymphoblastic leukemia.
Alves CH; Kuperman H; Dichtchekenian V; Damiani D; Della Manna T; Cristófani LM; Odone Filho V; Setian N
Rev Hosp Clin Fac Med Sao Paulo; 2004 Apr; 59(2):67-70. PubMed ID: 15122420
[TBL] [Abstract][Full Text] [Related]
10. Final height and puberty in 40 patients after antileukaemic treatment during childhood.
Mohnike K; Dörffel W; Timme J; Kluba U; Aumann V; Vorwerk P; Mittler U
Eur J Pediatr; 1997 Apr; 156(4):272-6. PubMed ID: 9128810
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of treatment for acute lymphoblastic leukemia with and without cranial irradiation on growth and puberty: a comparative study.
Hokken-Koelega AC; van Doorn JW; Hählen K; Stijnen T; de Muinck Keizer-Schrama SM; Drop SL
Pediatr Res; 1993 Jun; 33(6):577-82. PubMed ID: 8378115
[TBL] [Abstract][Full Text] [Related]
12. Analysis of growth failure in children treated for acute lymphoblastic leukemia.
Sato J; Ninomiya T; Tsuda Y; Komazawa M; Nagata K; Iwai A; Nishikawa K; Maeda H; Ohmiya A; Ohta M
Int J Hematol; 1992 Dec; 56(3):205-12. PubMed ID: 1477332
[TBL] [Abstract][Full Text] [Related]
13. Growth and growth hormone secretion after treatment for acute lymphoblastic leukemia in childhood. 18-Gy versus 24-Gy cranial irradiation.
Stubberfield TG; Byrne GC; Jones TW
J Pediatr Hematol Oncol; 1995 May; 17(2):167-71. PubMed ID: 7749768
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid excitatory amino acids and tau protein in children with acute lymphoblastic leukemia treated according to the BFM protocol.
Holownia A; Trofimiuk E; Krawczuk-Rybak M; Jakubow P; Kaliszewski J; Muszynska-Roslan K; Braszko JJ
Acta Haematol; 2004; 112(4):222-4. PubMed ID: 15564737
[No Abstract] [Full Text] [Related]
15. Changes in the EEG background activity of children with acute lymphoblastic leukemia during cytotoxic therapy.
Lichter-Konecki U; Benninger C; Brandeis WE; Matthis P; Scheffner D
Pediatr Hematol Oncol; 1987; 4(1):77-85. PubMed ID: 3152916
[TBL] [Abstract][Full Text] [Related]
16. Growth patterns and final height of survivors of childhood leukemia.
Jaruratanasirikul S; Owasith K; Wongchanchailert M; Laosombat V; Sriplung H
J Pediatr Endocrinol Metab; 2004 May; 17(5):719-26. PubMed ID: 15237705
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal growth and risk factors for growth deficiency in children treated for acute lymphoblastic leukemia.
Vilela MI; Viana MB
Pediatr Blood Cancer; 2007 Jan; 48(1):86-92. PubMed ID: 16700045
[TBL] [Abstract][Full Text] [Related]
18. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects on bone mineral density of different therapeutic schemes for acute lymphoblastic leukemia or non-Hodgkin lymphoma during childhood.
Benmiloud S; Steffens M; Beauloye V; de Wandeleer A; Devogelaer JP; Brichard B; Vermylen C; Maiter D
Horm Res Paediatr; 2010; 74(4):241-250. PubMed ID: 20395671
[TBL] [Abstract][Full Text] [Related]
20. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
Mora J; Filippa DA; Qin J; Wollner N
Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
